Cancer Immunotherapy: CAR T as 'Car Race'

GEN Podcasts

English - March 10, 2017 17:44 - 3 minutes - 3.37 MB - ★★★★★ - 4 ratings
Technology biotech biotechnology bioprocessing cell and gene therapy drug discovery gene editing genomics molecular biology cancer research next gen sequencing Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Turning Patients' Cells into Therapeutic Antibody Factories

Next Episode: Sensitive Genotypes and their Impact on Economic Success

GEN Sounds of Science March 9, 2017Brad Loncar, CEO of Loncar Investments, weighs in on recent developments in the scramble to develop CAR T cancer immunotherapies. How significant a setback is Juno Therapeutics’ halting development of JCAR015? How could some second-tier companies yet come out on top in the “car race”?

Hosted on Acast. See acast.com/privacy for more information.